West Pharmaceutical Services

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the design, manufacture, and sale of containment and delivery systems for injectable drugs and healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments.

CEO

Eric Mark Green

CEOEric Mark Green

Employees

10,800

Employees10,800

Headquarters

Exton, Pennsylvania

HeadquartersExton, Pennsylvania

Founded

1923

Founded1923

Employees

10,800

Employees10,800

WST Key Statistics

Market cap

25.38B

Market cap25.38B

Price-Earnings ratio

47.81

Price-Earnings ratio47.81

Dividend yield

0.24%

Dividend yield0.24%

Average volume

705.72K

Average volume705.72K

High today

$360.59

High today$360.59

Low today

$354.19

Low today$354.19

Open price

$358.44

Open price$358.44

Volume

494.32K

Volume494.32K

52 Week high

$367.66

52 Week high$367.66

52 Week low

$206.80

52 Week low$206.80

Stock Snapshot

With a market cap of 25.38B, West Pharmaceutical Services(WST) trades at $359.00. The stock has a price-to-earnings ratio of 47.81 and currently yields dividends of 0.24%.

As of 2026-07-15, West Pharmaceutical Services(WST) stock has fluctuated between $354.19 and $360.59. The current price stands at $359.00, placing the stock +1.4% above today's low and -0.4% off the high.

The West Pharmaceutical Services(WST)'s current trading volume is 494.32K, compared to an average daily volume of 705.72K.

During the past year, West Pharmaceutical Services(WST) stock moved between $206.80 at its lowest and $367.66 at its peak.

WST News

Nasdaq 9h

Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership

Avantor AVTR recently announced that its NuSil brand has expanded the long-standing collaboration with the Population Council to support the development of a ne...

TipRanks 9h

West Pharmaceutical price target raised to $410 from $365 at TD Cowen

TD Cowen raised the firm’s price target on West Pharmaceutical (WST) to $410 from $365 and keeps a Buy rating on the shares. The firm cites an improved earnings...

TipRanks 15h

West Pharmaceutical renews Daikyo technology and distribution pact

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. R...

Analyst ratings

84%

of 19 ratings

Buy

84.2%

Hold

10.5%

Sell

5.3%

More WST News

Simply Wall St 5d

West Pharmaceutical Services Sells SmartDose Rights, Is The Stock Fully Priced?

Advertisement Why the SmartDose 3.5mL sale matters for West Pharmaceutical Services stock West Pharmaceutical Services (WST) has completed the sale and transf...

Simply Wall St 6d

The Bull Case For West Pharmaceutical Services Could Change Following Its Q1 2026 Earnings Beat And Upgrades - Learn Why

West Pharmaceutical Services recently reported that it delivered strong first-quarter 2026 earnings and revenue, outpacing industry benchmarks and supporting it...

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.